Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Ten Haaf

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|February 11, 2020
Disparities of National Lung Cancer Screening Guidelines in the US PopulationSummer S Han, Eric Chow, Kevin Ten Haaf, et al.
Plos Medicine|February 8, 2017
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, CanadaKevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, et al.
Plos Medicine|September 25, 2020
Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation studyKevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, et al.
Plos Medicine|April 5, 2017
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation studyKevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, et al.
International Journal of Public Health|February 6, 2026
Eligibility for Lung Cancer Screening in Switzerland: A Comparative Analysis of Three Data Sources From Lausanne and the Canton of VaudLouis Gros, Cynthia Schneider, May-Lucie Meyer, et al.
Thorax|April 1, 2017
Risk stratification based on screening history: the NELSON lung cancer screening studyUraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, et al.
International Journal of Cancer|July 12, 2025
Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol-A modeling studyKoen de Nijs, Kevin Ten Haaf, Juul Hubert, et al.
JAMA Oncology|April 29, 2021
Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant WomenGlen B Taksler, Elisabeth F P Peterse, Isarah Willems, et al.
Nature Communications|August 28, 2025
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trialsMax Welz, Carlijn M van der Aalst, Andreas Alfons, et al.
Annals of Internal Medicine|November 5, 2019
Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling StudySteven D Criss, Pianpian Cao, Mehrad Bastani, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|February 11, 2020
Disparities of National Lung Cancer Screening Guidelines in the US PopulationSummer S Han, Eric Chow, Kevin Ten Haaf, et al.
Plos Medicine|February 8, 2017
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, CanadaKevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, et al.
Plos Medicine|September 25, 2020
Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation studyKevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, et al.
Plos Medicine|April 5, 2017
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation studyKevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, et al.
International Journal of Public Health|February 6, 2026
Eligibility for Lung Cancer Screening in Switzerland: A Comparative Analysis of Three Data Sources From Lausanne and the Canton of VaudLouis Gros, Cynthia Schneider, May-Lucie Meyer, et al.
Thorax|April 1, 2017
Risk stratification based on screening history: the NELSON lung cancer screening studyUraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, et al.
International Journal of Cancer|July 12, 2025
Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol-A modeling studyKoen de Nijs, Kevin Ten Haaf, Juul Hubert, et al.
JAMA Oncology|April 29, 2021
Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant WomenGlen B Taksler, Elisabeth F P Peterse, Isarah Willems, et al.
Nature Communications|August 28, 2025
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trialsMax Welz, Carlijn M van der Aalst, Andreas Alfons, et al.
Annals of Internal Medicine|November 5, 2019
Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling StudySteven D Criss, Pianpian Cao, Mehrad Bastani, et al.
Pageof 8